CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in patients with non-surgically removable locally advanced or metastatic triple...
Phase 2
Santa Monica, California, United States and 44 other locations
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Los Angeles, California, United States and 49 other locations
with balstilimab and to see how well they they work in shrinking tumors in patients with triple negative breast c...
Phase 1, Phase 2
Los Angeles, California, United States of America
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...
Phase 2
Santa Monica, California, United States and 23 other locations
This phase I trial tests the safety, side effects, and best dose of CF33-hNIS-antiPDL1 in treating patients with triple negative br ...
Phase 1
Duarte, California, United States
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Los Angeles, California, United States and 216 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Los Angeles, California, United States and 160 other locations
This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...
Phase 3
Burbank, California, United States and 199 other locations
(weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast cancer (MTNBC) patients....
Phase 1, Phase 2
Los Angeles, California, United States of America and 1 other location
This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...
Phase 1
Los Angeles, California, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal